60
Views
14
CrossRef citations to date
0
Altmetric
Original Research

Decreased pretherapy serum apolipoprotein A-I is associated with extent of metastasis and poor prognosis of non-small-cell lung cancer

, , , , , , , & show all
Pages 6995-7003 | Published online: 15 Oct 2018

References

  • HerbstRSMorgenszternDBoshoffCThe biology and management of non-small cell lung cancerNature2018553768944645429364287
  • JonesCMBrunelliACallisterMEFranksKNMultimodality treatment of advanced non-small cell lung cancer: where are we with the evidence?Curr Surg Rep201862529456881
  • de RuysscherDFaivre-FinnCLe PechouxCPeetersSBelderbosJHigh-dose re-irradiation following radical radiotherapy for non-small-cell lung cancerLancet Oncol20141513e620e62425456380
  • Xu-WelliverMCarboneDPBlood-based biomarkers in lung cancer: prognosis and treatment decisionsTransl Lung Cancer Res20176670871229218272
  • van HemelrijckMWalldiusGJungnerILow levels of apolipoprotein A-I and HDL are associated with risk of prostate cancer in the Swedish AMORIS studyCancer Causes Control20112271011101921562751
  • LuoXLZhongGZHuLYLyHSerum apolipoprotein A-I is a novel prognostic indicator for non-metastatic nasopharyngeal carcinomaOncotarget2015641440374404826503474
  • WangLChiPDChenHXiangJXiaZJZhangYJLow level of high-density lipoprotein cholesterol correlates with poor prognosis in extranodal natural killer/T cell lymphomaTumour Biol20143532141214924122233
  • ChiPDLiuWChenHHigh-density lipoprotein cholesterol is a favorable prognostic factor and negatively correlated with C-reactive protein level in non-small cell lung carcinomaPLoS One201493e9108024625581
  • DavidsonWSThompsonTBThe structure of apolipoprotein A-I in high density lipoproteinsJ Biol Chem200728231222492225317526499
  • PollardRDFulpBSamuelMPSorci-ThomasMGThomasMJThe conformation of lipid-free human apolipoprotein A-I in solutionBiochemistry201352529470948124308268
  • KuzuOFNooryMARobertsonGPThe role of cholesterol in cancerCancer Res20167682063207027197250
  • TamuraTInagawaSHisakuraKEnomotoTOhkohchiNEvaluation of serum high-density lipoprotein cholesterol levels as a prognostic factor in gastric cancer patientsJ Gastroenterol Hepatol201227101635164022647147
  • GuoSHeXChenQThe effect of preoperative apolipoprotein A-I on the prognosis of surgical renal cell carcinoma: a retrospective large sample studyMedicine20169512e314727015197
  • WangXPLiXHZhangLHigh level of serum apolipoprotein A-I is a favorable prognostic factor for overall survival in esophageal squamous cell carcinomaBMC Cancer20161651627444612
  • ChengTDaiXZhouDLLvYMiaoLYCorrelation of apolipoprotein A-I kinetics with survival and response to first-line platinum-based chemotherapy in advanced non-small cell lung cancerMed Oncol201532140725465061
  • GroomePABolejackVCrowleyJJThe IASLC Lung Cancer Staging Project: validation of the proposals for revision of the T, N, and M descriptors and consequent stage groupings in the forthcoming (seventh) edition of the TNM classification of malignant tumoursJ Thorac Oncol20072869470517762335
  • MichalakiVKoutroulisGSyrigosKPiperiCKalofoutisAEvaluation of serum lipids and high-density lipoprotein subfractions (HDL2, HDL3) in postmenopausal patients with breast cancerMol Cell Biochem20052681–2192415724433
  • Zamanian-DaryoushMDidonatoJAApolipoprotein A-I and cancerFront Pharmacol2015626526617517
  • BorgquistSButtTAlmgrenPApolipoproteins, lipids and risk of cancerInt J Cancer2016138112648265626804063
  • JafriHAlsheikh-AliAAKarasRHBaseline and on-treatment high-density lipoprotein cholesterol and the risk of cancer in randomized controlled trials of lipid-altering therapyJ Am Coll Cardiol201055252846285420579542
  • KozakKRAmneusMWPuseySMIdentification of biomarkers for ovarian cancer using strong anion-exchange ProteinChips: potential use in diagnosis and prognosisProc Natl Acad Sci U S A200310021123431234814523236
  • LaneDMBoatmanKKMcconathyWJSerum lipids and apolipoproteins in women with breast massesBreast Cancer Res Treat19953421611697647333
  • Kucharska-NewtonAMRosamondWDSchroederJCHDL-cholesterol and the incidence of lung cancer in the Atherosclerosis Risk in Communities (ARIC) studyLung Cancer200861329230018342390
  • von EckardsteinAHersbergerMRohrerLCurrent understanding of the metabolism and biological actions of HDLCurr Opin Clin Nutr Metab Care20058214715215716792
  • SharmaSUmarSPotusFApolipoprotein A-I mimetic peptide 4F rescues pulmonary hypertension by inducing microRNA-193-3pCirculation2014130977678524963038
  • Zamanian-DaryoushMLindnerDTallantTCThe cardioprotective protein apolipoprotein A1 promotes potent anti-tumorigenic effectsJ Biol Chem201328829212372125223720750
  • CruzPMMoHMcconathyWJSabnisNLackoAGThe role of cholesterol metabolism and cholesterol transport in carcinogenesis: a review of scientific findings, relevant to future cancer therapeuticsFront Pharmacol2013411924093019
  • AsegaonkarSBAsegaonkarBNTakalkarUVAdvaniSThoratAPC-reactive protein and breast cancer: new insights from old moleculeInt J Breast Cancer2015201514564726693355
  • TietgeUJMaugeaisCCainWOverexpression of secretory phospholipase A(2) causes rapid catabolism and altered tissue uptake of high density lipoprotein cholesteryl ester and apolipoprotein A-IJ Biol Chem200027514100771008410744687